Optimmune Ophthalmic Ointment 0.2%
This item requires prescription approval.
Prescription medications are currently limited to CA residents. More states coming soon!!
- Product Description
- Safety Information
- Additional Information
Optimmune Ophthalmic Ointment is indicated for management of chronic keratoconjunctivitis sicca (KCS or dry eye) and chronic superficial keratitis (CSK) in dogs. It helps reduce inflammation and irritation and increases tear production for your pet
- The only FDA-approved veterinary cyclosporine ophthalmic product.
- Achieves therapeutic effect while avoiding systemic toxicity.
- Sterile, preservative-free formulation reduces the chance of secondary infection and chemical irritation.
- Shelf life up to 24 months with no refrigeration.
Consult with your veterinarian for proper dosage and course of treatment.
Not for use on cats or other animals.
The clinical effects of OPTIMMUNE® Ophthalmic Ointment have not been determined in dogs with KCS due to the following conditions: congenital alacrima, sulfonamide usage, canine distemper virus, metabolic disease, surgical removal of the third eyelid gland, and facial nerve paralysis with loss of the palpebral reflex. Some of the underlying conditions which may lead to KCS can be either transient (eg, facial nerve trauma) or correctable with appropriate treatment. Consequently, recovery from clinical signs attributed to KCS may be observed and treatment options may need reconsideration.
When switching to cyclosporine from another therapeutic agent (eg, frequent application of an artificial tear preparation) for KCS or CSK, it should be kept in mind that clinical efficacy is not necessarily apparent immediately after initiation of OPTIMMUNE® Ophthalmic Ointment therapy. Several days to a few weeks may be required before the clinical effects of OPTIMMUNE® Ophthalmic Ointment are of sufficient magnitude such that previously initiated therapy can be safely withdrawn. Abrupt cessation of a therapeutic agent immediately upon initiation of OPTIMMUNE® Ophthalmic Ointment therapy can result in rapid clinical relapse which may be erroneously interpreted as an adverse reaction to OPTIMMUNE® Ophthalmic Ointment.
The safety of OPTIMMUNE® Ophthalmic Ointment has not been determined in cases of preexisting viral or fungal ocular infections. It is recommended that in such cases, OPTIMMUNE® Ophthalmic Ointment therapy be delayed until the fungal/viral ocular infection has been successfully treated.
The safety of OPTIMMUNE® Ophthalmic Ointment in puppies, pregnant bitches, or dogs used for breeding has not been determined.
Food and Drug Interactions
Other medications can interact with Optimmune Ophthalmic Ointment , be sure to disclose every medication and supplement that is given to your dog before starting Optimmune.
Wash hands before and after applying medication to pet.
Possible Side Effects
In clinical trials, reactions like excessive watering of eye, mild discomfort of the eye and mild alopecia were reported in 12.9% of dogs enrolled in this trial.
In rare occasions, Optimmune may be associated with redness and irritation, lid spasm, and excessive rubbing.
Store at controlled room temperature between 36° and 77° F